| 영문 | interstitial therapy | 한글 | 근접치료 |
|---|---|---|---|
| 설명 | 주로 종양의 치료를 목적으로 하여 인체 조직내에 방사선 물질을 삽입하여 방사선을 조사하는 치료법이다. Brachytherapy라고도 한다. |
||
| 영문 | nephritis(interstitial) | 한글 | 콩팥염, 신장염(간질성) |
|---|---|---|---|
| 설명 | 콩팥사이질(renal interstitium: 콩팥의 세뇨관 사이의 결합조직)의 염증. 급성으로 일어나는 간질콩팥염은 대개 많은 약을 복용한 후에 발생하는 데, 열, 피부의 변색, 혈액내의 호산구증 그리고 소변의 감소와 콩팥기능의 감소를 특징으로 한다. 치료는 복용중인 약을 끊고, 부신겉질호르몬제를 투여한다. 콩팥은 각종 노폐물, 전해질, 수분 등을 포함한 요를 생산하여 배출하는 동시에 수소이온, 나트륨, 칼륨, 인산 이온 농도 등을 조절하며 내분비와 외분비 기능에 관여하기도 한다. |
||
| 영문 | heart-lung machine | 한글 | 심장-허파 기계 |
|---|---|---|---|
| 설명 | 심장의 수술에 사용되는 기계로서 심장이 수술을 받고 있는 동안 기능을 하지 못하므로 이 기능을 대신 해주는 기계이다. 이것은 대정맥과 대동맥사이에 연결이 되어서 혈액을 강제로 순환시키면서 대정맥에서 온 피에 산소를 공급하여 대동맥으로 돌려 보내는 역할을 한다. 즉 심장과 폐의 역할을 동시에 하는 기계이다. |
||
| 영문 | total lung capacity | 한글 | 전폐용량, 온허파용량 |
|---|---|---|---|
| 설명 | 폐활량(가능한 한 깊게 들여 마신 시점부터 천천히 한껏 내쉰 용량)에 잔기량(최대 날숨위치에서 폐내에 남은 용량. 약 1,200mL)을 합한 것이다. 건강한 성인은 6,000~7,000mL. 폐기종, 만성 기관지염 등의 폐색성 장애로 증가하게 되는 한편 허파섬유증, 무기폐, 흉수, 흉곽변형 등의 구속성 장애로 감소한다. |
||
| 영문 | lung cancer | 한글 | 폐암 |
|---|---|---|---|
| 설명 | 허파에 생기는 악성종양이다. 가장 예후가 나쁜 종양중의 하나로써 조기발견이 어렵고 증세 또한 늦게 나타나서, 그 종양의 종류에 따라 다르나 치료후에도 대개 8%만이 5년 생존이 가능한 악성종양이다. 유발인자로는 대표적으로 담배가 알려져 있으며, 유전적인 요소도 어느 정도 기여하는 것으로 알려져 있다. |
||
| AML | Acute Myelogenous Leukemia Morphologic Classification(FAB분류) &n... |
|---|---|
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
| AML | acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukem... |
| DILD | diffuse infiltrative lung disease; diffuse interstitial lung disease |
| AP | accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p... |
| ILD | Interstitial Lung Disease |
|---|---|
| DILD | diffuse interstitial lung disease |
| AIN | Acute interstitial nephritis |
| AIP | acute interstitial pneumonia |
acute angle
acute arthritis
acute monocytic leukemia
| apical interstitial lung disease | <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs. Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection. (25 Jun 1999) |
|---|---|
| basilar interstitial lung disease | <radiology> B bronchiectasis, A asbestosis, D drugs / DIP, L lymphangitic metastasis / LAM, A aspiration, S sarcoidosis, S scleroderma (12 Dec 1998) |
| interstitial lung disease | <chest medicine> A group of lung disorders which result in scarring and dysfunction of the alveolus (air sac) in the lung. This results in poor oxygen diffusion from the air into the bloodstream. Widespread inflammation in the lung leads to fibrosis (scarring). Causes include chronic exposure to organic and inorganic dusts, fumes, vapors, radiation, medications and certain lung infections. Examples include asbestosis, silicosis, coal worker's pneumoconiosis and diffuse interstitial fibrosis. Smoking increases the risk in all cases. (27 Sep 1997) |
| interstitial lung disease with increased volume | <radiology> Cystic fibrosis (CF), eosinophilic granuloma (EG), lymphangioleiomyomatosis (LAM) (12 Dec 1998) |
| lung diseases, interstitial | A heterogeneous group of noninfectious, nonmalignant disorders of the lower respiratory tract, affecting primarily the alveolar wall structures but also often involving the small airways and blood vessels of the lung parenchyma. "interstitial" refers to the fact that the interstitium of the alveolar walls is thickened, usually by fibrosis. This group of diseases is usually inflammatory. (12 Dec 1998) |
| acute interstitial nephritis | <nephrology> A relatively uncommon condition which is characterised by inflammation of the renal tubules, glomeruli and surrounding tissue. Interstitial nephritis is usually be temporary and often associated with the use of a particular medication. Chronic and progressive forms do exist. Drugs that have been associated with interstitial nephritis include penicillins, ampicillin, sulpha drugs, non-steroidal anti-inflammatory agents, furosemide and thiazide diuretics. May result in mild kidney dysfunction or acute renal failure. Treatment may be with corticosteroids. Incidence: 1 in 25,000. (29 Dec 1997) |
| acute interstitial pneumonia | A severe and usually fatal form of pneumonia occurring primarily in infants usually considered a form of hypersensitivity pneumonitis. (05 Mar 2000) |
| acute interstitial pneumonitis | Usually considered a form of hypersensitivity pneumonitis. (05 Mar 2000) |
| chronic interstitial hepatitis | An obsolete term for cirrhosis of the liver. (05 Mar 2000) |
| chronic interstitial hypertrophic neuropathy | dejerine-Sottas disease |
| chronic interstitial salpingitis | Salpingitis in which fibrosis or mononuclear cell infiltration involves all layers of the fallopian or eustachian tube. Synonym: pachysalpingitis. (05 Mar 2000) |
| pneumonia, atypical interstitial, of cattle | A cattle disease of uncertain cause, probably an allergic reaction. (12 Dec 1998) |
| pneumonia, progressive interstitial, of sheep | Chronic respiratory disease caused by the visna-maedi virus. It was formerly believed to be identical with jaagsiekte (pulmonary adenomatosis, ovine) but is now recognised as a separate entity. (12 Dec 1998) |
| cystitis, interstitial | Disease that involves inflammation or irritation of the bladder wall. This inflammation can lead to scarring and stiffening of the bladder, and even ulcerations and bleeding. Diagnosis is based on symptoms, findings on cystoscopy and biopsy, and eliminating other treatable causes such as infection. Because doctors do not know what causes IC, treatments are aimed at relieving symptoms. most people are helped for variable periods of time by one or a combination of treatments. (12 Dec 1998) |
| hypertrophic interstitial neuropathy | Sensorimotor neuropathy characterised pathologically by collections of Schwann cell processes arranged concentrically around one or more nerve fibres. No genetic factors are known in its aetiology.For hereditary types, see hereditary hypertrophic neuropathy. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|